Back

Vericiquat.

29 April 2017 (15:57 - 16:15)
Organised by:
Congress Presentation Part of: Novel drugs in acute heart failure: hurdles, hype and hope Acute heart failure (therapy) HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Professor Burkert Pieske

Rostock University Medical Centre Part of the Rostock University, Rostock (Germany)

4 More presentations in this session

Presentation thumbnail
Serelaxin.
Professor M. Metra (Milan, IT)
Slides Video
Presentation thumbnail
HNO Donors.
Professor J. Butler (Dallas, US)
Slides Video
Presentation thumbnail
Omecamtiv mecarbil
Professor J. Teerlink (San Francisco, US)
Slides Video
Presentation thumbnail
Elamipretide.
Professor H. Sabbah (Detroit, US)
Slides Video

Access the full session

Session thumbnail
Novel drugs in acute heart failure: hurdles, hype and hope

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April 2017 15:57 CET
You may be interested in
thumbnail
Congress Presentation
The enhanced HFrEF medication toolkit in practice
30 August 2026
thumbnail
Congress Presentation
Vericiguat clinical pharmacology programme: biopharmaceutical properties and potential intrinsic and extrinsic factor effects
28 August 2020
thumbnail
Congress Presentation
Efficacy and safety of vericiguat in patients with HFrEF treated with sacubitril/valsartan: results from the VICTORIA trial
27 August 2021
thumbnail
Congress Presentation
Monitoring the electrophysiological effects of hydroquinidine non-invasively in patients with Brugada syndrome
27 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources